David Franklyn
Director
Management
Bay Zoltan Nonprofit Public Ltd. for Applied Research
Australia
Biography
Dimerix Limited is a clinical stage, biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB). The Company is focused on developing new therapeutic treatments identified using its proprietary drug discovery platform, Receptor-Heteromer Investigation Technology (HIT).
Research Interest
Ocular Otology Allergy Inflammation Fatigue
